Published in Lancet on February 08, 1975
Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis (1982) 1.03
High dose intravenous methylprednisolone pulse therapy in patients with rheumatoid arthritis. Ann Rheum Dis (1990) 0.81
Which cyclosporin formulation? Lancet (1996) 3.34
Campylobacter fetus diarrhea in a Hutterite colony: epidemiological observations and typing of the causative organism. J Clin Microbiol (1994) 3.31
Consensus statement on the live organ donor. JAMA (2000) 3.29
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet (1994) 1.94
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Hybridization between introduced smooth cordgrass (Spartina alterniflora; Poaceae) and native California cordgrass (S. foliosa) in San Francisco Bay, California, USA. Am J Bot (1997) 1.41
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Lead nephropathy. Kidney Int (1985) 1.24
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Use of item response theory to understand differential functioning of DSM-IV major depression symptoms by race, ethnicity and gender. Psychol Med (2008) 1.14
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
A guide to drug therapy in renal failure. JAMA (1974) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97
Cyclosporine-associated hypertension. Am J Med (1988) 0.97
Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96
Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96
A practical guide to drug usage in adult patients with impaired renal function. JAMA (1970) 0.96
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96
Is there cognitive decline in schizophrenia? A cross-sectional study. Br J Psychiatry (1994) 0.95
Herpes simplex type 1 hepatitis in renal transplantation. Arch Intern Med (1980) 0.95
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95
Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother (1982) 0.95
Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity. J Lab Clin Med (1982) 0.94
Urologic complications in 173 kidney transplants. J Urol (1974) 0.94
Clinical, EEG, and quantitative MRI differences in pediatric frontal and temporal lobe epilepsy. Neurology (2002) 0.93
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int (1997) 0.93
Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance. Ann Intern Med (1981) 0.93
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J (2010) 0.92
Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Ann N Y Acad Sci (1983) 0.92
Guide to drug usage in adult patients with impaired renal function. A supplement. JAMA (1973) 0.92
Alterations in organic ion transport induced by gentamicin nephrotoxicity in the rat. J Lab Clin Med (1980) 0.92
Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol (1993) 0.92
Transient diabetes insipidus complicating systemic fat embolization. J Trauma (1972) 0.91
Renal transport of organic acids and bases in aminoglycoside nephrotoxicity. Antimicrob Agents Chemother (1979) 0.91
Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis (1999) 0.91
Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats. Antimicrob Agents Chemother (1980) 0.91
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation (1997) 0.91
Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91
Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics. Ann Intern Med (1980) 0.90
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation (1997) 0.90
Myeloid bodies in the renal tubules of humans: relationship to gentamicin therapy. Clin Nephrol (1978) 0.89
Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole. JAMA (1976) 0.89
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int (2000) 0.89
Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab (1995) 0.89
Effect of basis amino acids and aminoglycosides on 3H-gentamicin uptake in cortical slices of rat and human kidney. J Lab Clin Med (1982) 0.89
Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol (1987) 0.88
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int (1995) 0.88
"Dewlap". A corticosteroid-induced episternal fatty tumor. N Engl J Med (1966) 0.88
Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc (1986) 0.88
Drug prescribing in renal failure. Drugs (1979) 0.88
FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. Lab Invest (1995) 0.88
Factors in cardiac risk stratification of candidates for renal transplant. J Cardiovasc Risk (1999) 0.88
Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf (1999) 0.87
Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity in rats. Res Commun Chem Pathol Pharmacol (1980) 0.87
Responsibilities of primary physicians in organ donation. Ann Intern Med (1987) 0.87
Increasing dietary calcium moderates experimental gentamicin nephrotoxicity. J Lab Clin Med (1984) 0.86